1 Spinney L, "Uncovering the true prevalence of Huntington’s disease" 9 : 760-761, 2010
2 Duyao M, "Trinucleotide repeat length instability and age of onset in Huntington’s disease" 4 : 387-392, 1993
3 Hayden MR, "The prevalence of Huntington’s chorea in South Africa" 58 : 193-196, 1980
4 Maat-Kievit A, "New problems in testing for Huntington’s disease: the issue of intermediate and reduced penetrance alleles" 38 : E12-, 2001
5 Falush D, "Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases" 68 : 373-385, 2001
6 Palo J, "Low prevalence of Huntington’s disease in Finland" 2 : 805-806, 1987
7 Sequeiros J, "Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population" 78 : 381-387, 2010
8 Ramos-Arroyo MA, "Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing" 76 : 337-342, 2005
9 Chang CM, "Huntington’s disease in Hong Kong Chinese: epidemiology and clinical picture" 31 : 43-51, 1994
10 Conneally PM, "Huntington disease: genetics and epidemiology" 36 : 506-526, 1984
1 Spinney L, "Uncovering the true prevalence of Huntington’s disease" 9 : 760-761, 2010
2 Duyao M, "Trinucleotide repeat length instability and age of onset in Huntington’s disease" 4 : 387-392, 1993
3 Hayden MR, "The prevalence of Huntington’s chorea in South Africa" 58 : 193-196, 1980
4 Maat-Kievit A, "New problems in testing for Huntington’s disease: the issue of intermediate and reduced penetrance alleles" 38 : E12-, 2001
5 Falush D, "Measurement of mutational flow implies both a high new-mutation rate for Huntington disease and substantial underascertainment of late-onset cases" 68 : 373-385, 2001
6 Palo J, "Low prevalence of Huntington’s disease in Finland" 2 : 805-806, 1987
7 Sequeiros J, "Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population" 78 : 381-387, 2010
8 Ramos-Arroyo MA, "Incidence and mutation rates of Huntington’s disease in Spain: experience of 9 years of direct genetic testing" 76 : 337-342, 2005
9 Chang CM, "Huntington’s disease in Hong Kong Chinese: epidemiology and clinical picture" 31 : 43-51, 1994
10 Conneally PM, "Huntington disease: genetics and epidemiology" 36 : 506-526, 1984
11 Warby SC, "HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia" 19 : 561-566, 2011
12 Nakashima K, "Epidemiological and genetic studies of Huntington’s disease in the San-in area of Japan" 15 : 126-131, 1996
13 Squitieri F, "DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence" 3 : 2103-2114, 1994
14 Chong SS, "Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses" 6 : 301-309, 1997
15 Warby SC, "CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup" 84 : 351-366, 2009
16 Kremer B, "A worldwide study of the Huntington’s disease mutation. The sensitivity and specificity of measuring CAG repeats" 330 : 1401-1406, 1994
17 Huntington’s Disease Collaborative Research Group, "A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes" 72 : 971-983, 1993
18 Stephens M, "A new statistical method for haplotype reconstruction from population data" 68 : 978-989, 2001
19 Soong BW, "A comparison of the Huntington’s disease associated trinucleotide repeat between Chinese and white populations" 32 : 404-405, 1995